Financial Gravity Asset Management, Inc. Liva Nova PLC Transaction History

Financial Gravity Asset Management, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$48.6 - $57.12 $534 - $628	11 Added 1100.0%	12 $661,000
Q4 2023 Jun 26, 2024	SELL	$43.45 - $53.66 $477 - $590	-11 Reduced 91.67%	1 $93,000
Q3 2023 Nov 15, 2023	SELL	$50.12 - $58.87 $2,506 - $2,943	-50 Reduced 98.04%	1 $0
Q2 2023 Aug 08, 2023	BUY	$42.28 - $51.43 $295 - $360	7 Added 15.91%	51 $753,000
Q1 2023 May 12, 2023	SELL	$40.84 - $58.14 $490 - $697	-12 Reduced 21.43%	44 $77,000
Q4 2022 Feb 15, 2023	SELL	$43.88 - $56.16 $6,494 - $8,311	-148 Reduced 72.55%	56 $1.29 Million
Q3 2022 Nov 03, 2022	SELL	$48.37 - $66.5 $2,128 - $2,926	-44 Reduced 17.74%	204 $90,000
Q2 2022 Aug 05, 2022	SELL	$57.25 - $86.63 $93,775 - $141,899	-1,638 Reduced 86.85%	248 $111,000
Q1 2022 May 13, 2022	SELL	$71.02 - $86.99 $63,775 - $78,117	-898 Reduced 32.26%	1,886 $2.19 Million
Q4 2021 Feb 11, 2022	BUY	$76.72 - $92.68 $209,215 - $252,738	2,727 Added 4784.21%	2,784 $4.73 Million
Q3 2021 Nov 12, 2021	BUY	$76.02 - $88.62 $4,333 - $5,051	57 New	57 $79,000
Q4 2019 Feb 28, 2020	SELL	$68.92 - $85.27 $35,493 - $43,914	-515 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$71.74 - $86.35 $10,976 - $13,211	-153 Reduced 22.9%	515 $38,000
Q2 2019 Jul 26, 2019	SELL	$66.45 - $97.36 $11,362 - $16,648	-171 Reduced 20.38%	668 $48,000
Q1 2019 Apr 19, 2019	BUY	$86.15 - $100.49 $16,885 - $19,696	196 Added 30.48%	839 $81,000
Q3 2018 Oct 31, 2018	BUY	$101.02 - $130.95 $24,446 - $31,689	242 Added 60.35%	643 $72,000
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $32,781 - $42,253	401 New	401 $49,000

274

55.2M

140K

44.5K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.23B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.